These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12325061)

  • 1. The impact of journal advertisements on prescribers of cholinesterase inhibitors.
    Sauer J; Howard R
    Int J Geriatr Psychiatry; 2002 Oct; 17(10):976-8. PubMed ID: 12325061
    [No Abstract]   [Full Text] [Related]  

  • 2. [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko].
    Gasser US; Gasser T
    MMW Fortschr Med; 2001 Dec; 143(51-52):40-1. PubMed ID: 11824165
    [No Abstract]   [Full Text] [Related]  

  • 3. Featured CME topic: dementia. Medication update.
    Slagle MA
    South Med J; 2001 Jul; 94(7):678-81. PubMed ID: 11531174
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanisms of action of Alzheimer medications].
    Alhainen K
    Duodecim; 2003; 119(20):1959-66. PubMed ID: 14640001
    [No Abstract]   [Full Text] [Related]  

  • 5. A case history illustrating how extended release cholinesterase inhibitors could improve management of Alzheimer's disease.
    Alisky JM
    J Alzheimers Dis; 2003 Dec; 5(6):477-8. PubMed ID: 14757938
    [No Abstract]   [Full Text] [Related]  

  • 6. Medications for the treatment of Alzheimer's disease.
    Lampley-Dallas VT
    J Okla State Med Assoc; 2001 Aug; 94(8):347-9. PubMed ID: 11515383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current treatments for Alzheimer's disease: cholinesterase inhibitors.
    Doody RS
    J Clin Psychiatry; 2003; 64 Suppl 9():11-7. PubMed ID: 12934969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to cholinesterase inhibitors in patients with Alzheimer's disease.
    Blais L; Kettani FZ; Perreault S; Leroux JC; Forget A; Kergoat MJ
    J Am Geriatr Soc; 2009 Feb; 57(2):366-8. PubMed ID: 19207161
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease.
    Prescrire Int; 2003 Dec; 12(68):230-1. PubMed ID: 14986699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.
    Prasher VP
    Int J Geriatr Psychiatry; 2004 Jun; 19(6):509-15. PubMed ID: 15211527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New drugs for Alzheimer's disease in Japan.
    Takeda M; Tanaka T; Okochi M
    Psychiatry Clin Neurosci; 2011 Aug; 65(5):399-404. PubMed ID: 21851448
    [No Abstract]   [Full Text] [Related]  

  • 12. The use, benefits, and costs of cholinesterase inhibitors for Alzheimer's dementia in long-term care: are the data relevant and available?
    Khang P; Weintraub N; Espinoza RT
    J Am Med Dir Assoc; 2004; 5(4):249-55. PubMed ID: 15228635
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of cholinesterase inhibitors for treatment of Alzheimer disease.
    Hake AM
    Cleve Clin J Med; 2001 Jul; 68(7):608-9, 613-4, 616. PubMed ID: 11453078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease: new pharmacological perspectives.
    Palacios JM
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():67-8. PubMed ID: 8899698
    [No Abstract]   [Full Text] [Related]  

  • 15. Switching from donepezil to galantamine: a double-blind study of two wash-out periods.
    Wilkinson DG; Howe I
    Int J Geriatr Psychiatry; 2005 May; 20(5):489-91. PubMed ID: 15852437
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-Alzheimer drugs: life-threatening adverse effects.
    Prescrire Int; 2007 Feb; 16(87):16. PubMed ID: 17326275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advertisements for donepezil (Aricept) in the BMJ. Advertisement suggests an unrealistic improvement in mental status.
    Gray S
    BMJ; 1997 May; 314(7093):1555. PubMed ID: 9183222
    [No Abstract]   [Full Text] [Related]  

  • 18. [Alzheimer's disease. Foreword].
    Derquesné C
    Rev Prat; 1998 Nov; 48(17):1871-2. PubMed ID: 9882238
    [No Abstract]   [Full Text] [Related]  

  • 19. Cholinesterase inhibitors in Alzheimer's disease: donepezil or rivastigmine?
    Sharma JC
    Int J Clin Pract; 2002; 56(6):414-5. PubMed ID: 12166537
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic agents for Alzheimer's disease].
    Honma A
    Nihon Naika Gakkai Zasshi; 1998 Jan; 87(1):169-74. PubMed ID: 9513562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.